✦ LIBER ✦

Dendritic/tumor fusion cell-based vaccination against cancer

✍ Scribed by Shigeo Koido; Eiichi Hara; Sadamu Homma; Kiyotaka Fujise; Jianlin Gong; Hisao Tajiri

Publisher: Springer
Year: 2007
Tongue: English
Weight: 103 KB
Volume: 55
Category: Article
ISSN: 0004-069X
DOI: 10.1007/s00005-007-0034-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dendritic-cell-based therapeutic vaccina

Dendritic-cell-based therapeutic vaccination against cancer

✍ Frank O Nestle; Arpad Farkas; Curdin Conrad 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Early clinical trials, in which over 1000 cancer patients received dendritic cell (DC) vaccines, tested different vaccine preparations, but they did not always induce sufficient acquired immunity or meet the expected level of tumor regressions. Current studies aim to improve the DC vaccine approach

Dendritic cell–tumor cell hybrid vaccina

Dendritic cell–tumor cell hybrid vaccination for metastatic cancer

✍ Jose Alexandre M. Barbuto; Luis F. C. Ensina; Andreia R. Neves; Patrícia C. Berg 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 285 KB

Whole-cell cancer vaccination: from auto

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines

✍ Tanja D. de Gruijl; Alfons J. M. van den Eertwegh; Herbert M. Pinedo; Rik J. Sch 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 311 KB

An autologous dendritic cell canine mamm

An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine

✍ R. Curtis Bird; Patricia DeInnocentes; Allison E. Church Bird; Frederik W. van G 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 605 KB

Immunotherapy of cancer with dendritic-c

Immunotherapy of cancer with dendritic-cell-based vaccines

✍ E. Gilboa; Smita K. Nair; H. Kim Lyerly 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 162 KB

Toll-like receptor agonists as third sig

Toll-like receptor agonists as third signals for dendritic cell–tumor fusion vaccines

✍ Edward I. Cho; Chunrui Tan; Gary K. Koski; Peter A. Cohen; Suyu Shu; Walter T. L 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

## Abstract ## Background The aim of the present study was to evaluate the therapeutic efficacy of dendritic cell (DC)–tumor fusion hybrids with Toll‐like receptor (TLR) agonists. ## Methods DC–tumor fusion hybrids were generated by electrofusion and injected into the inguinal lymph nodes of C57